Showing results (1-10 of 708) with videos related to

Sort By:
Pageof 71
Nature Reviews. Clinical Oncology|June 2, 2011
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?Katrien De Bock, Massimiliano Mazzone, Peter Carmeliet
Developmental Cell|February 17, 2009
Regulation of angiogenesis by oxygen and metabolismPeter Fraisl, Massimiliano Mazzone, Thomas Schmidt, et al.
Cancer Cell|March 3, 2009
Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisitedSonja Loges, Massimiliano Mazzone, Philipp Hohensinner, et al.
Nature Reviews. Cancer|November 26, 2008
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?Christian Fischer, Massimiliano Mazzone, Bart Jonckx, et al.
Nature Reviews. Clinical Oncology|June 2, 2009
Branching morphogenesis and antiangiogenesis candidates: tip cells lead the wayPeter Carmeliet, Frederik De Smet, Sonja Loges, et al.
Physiological Reviews|April 4, 2009
Role and therapeutic potential of VEGF in the nervous systemCarmen Ruiz de Almodovar, Diether Lambrechts, Massimiliano Mazzone, et al.
Blood|May 25, 2013
The "cord of life" serving antiangiogenic therapyMassimiliano Mazzone
The Journal of Experimental Medicine|May 7, 2008
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironmentCharlotte Rolny, Lorena Capparuccia, Andrea Casazza, et al.
Cell Metabolism|October 25, 2016
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and MetastasisMathias Wenes, Min Shang, Mario Di Matteo, et al.
Annual Review of Physiology|February 12, 2019
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and MetastasisMassimiliano Mazzone, Gabriele Bergers
Pageof 71